Stock 0KGB PATTERSON COMPANIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Patterson Companies, Inc. London S.E.

Equities

0KGB

US7033951036

Market Closed - London S.E.
Other stock markets
 15:30:30 28/04/2021 BST 		5-day change 1st Jan Change
32.38 USD +6.38% Intraday chart for Patterson Companies, Inc. +33.36% +15.40%
06-20 Morgan Stanley Adjusts Price Target on Patterson Companies to $28 From $30, Maintains Equalweight Rating MT
06-20 JPMorgan Adjusts Price Target on Patterson Companies to $29 From $30, Maintains Neutral Rating MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.38 times its sales.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The company is one of the best yield companies with high dividend expectations.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
PATTERSON COMPANIES, INC. Stock Patterson Companies, Inc.
+15.40% 2.12B -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-4.45% 101B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 67.54B
A
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 45.09B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.70% 44.37B
B-
HOYA CORPORATION Stock Hoya Corporation
+5.36% 40.7B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 29.85B
B
TERUMO CORPORATION Stock Terumo Corporation
+10.26% 24.49B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 23.99B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PDCO Stock
  4. 0KGB Stock
  5. Ratings Patterson Companies, Inc.